Aplasia cutis congenita following in utero methimazole exposure

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 5, 2007, Pages 585-586

  Baid, Smita K ^a   Merke, Deborah P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROPYLTHIOURACIL; THIAMAZOLE;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAVES DISEASE; HUMAN; MATERNAL TREATMENT; PHYSICAL EXAMINATION; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; SKIN APLASIA; SKIN DEFECT; TERATOGENICITY;

EID: 34250748016     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.5.585     Document Type: Article

References (2)

1. Vogt T, Stolz W, Landthaler M. Aplasia cutis congenital after exposure to methimazole: a causal relationship. Br J Dermatol 1995; 133: 994-996.
2. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 1999; 83: 43-46.